COVID-19 antiviral treatment remains relevant in 2026 for immunocompromised and high-risk patients. Molnulee, generic Molnupiravir from Unnati Pharmax, offers Chicago pharmacies and patients reliable, affordable supply.
The standard course is 800mg twice daily for 5 days, started as early as possible after a positive test. It works by introducing replication errors into the virus's genetic material, halting effective reproduction.
FAQ: Is Molnulee still effective against newer COVID variants in 2026?
Molnupiravir's mechanism — inducing mutations that prevent the virus from replicating accurately — is largely variant-independent, since it targets the fundamental replication process rather than specific spike protein mutations that vary between strains. This makes it generally effective regardless of which variant is circulating, though your physician should confirm current treatment guidance, as recommendations are periodically updated based on the latest variant surveillance data.
